Fig. 3: Designs confer sterile protection against sporozoite challenge.
From: A combined designed CSP and Pfs48/45 infection and transmission blocking vaccine for malaria
Protection of C57BL/6 mice from infection after challenge with 500 PfCSP transgenic P. berghei parasites. The statistical significance of differences in survival analysis was determined via Kaplan‒Meier survival analysis with Bonferroni correction for multiple comparisons.
